Professional
Added to YB: 2023-12-05
Pitch date: 2023-12-05
IDXX [bullish]
IDEXX Laboratories, Inc.
+35.11%
current return
Author Info
No bio for this author
Company Info
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Market Cap
$56.2B
Pitch Price
$521.19
Price Target
351.00 (-50%)
Dividend
N/A
EV/EBITDA
38.79
P/E
55.89
EV/Sales
13.71
Sector
Health Care Equipment and Supplies
Category
growth
[SHORT] IDEXX Laboratories: Fair Value Estimate Intact, Softness in Visit Volume Could Linger Into 2024
IDEXX Q3 in line, $351 FVE maintained despite 9% top-line growth below 10% historical avg. 30% op margin +100bps. Vet visits down on staff burnout, inflation. Narrow moat from analyzers, services. Leads convenience, integration. FX & rapid assay competition are risks. Steady growth expected but stock overvalued.
Read full article (9 min)